Interestingly, the correlation analysis between the expression levels of MCT1 and IDH1 in GBM patients was inversely proportional, further confirming recently obtained data in which mutant IDH1 expression was associated with the downregulation of monocarboxylate transporters (67). Here, SLC16A1 is linked to glioblastoma.